| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |